Machine Learning Models Reveal The Importance of Clinical Biomarkers for the Diagnosis of Alzheimer's Disease
Alzheimer's Disease (AD) is a neurodegenerative disease that causes complications with thinking capability, memory and behavior. AD is a major public health problem among the elderly in developed and developing countries. With the growth of AD around the world, there is a need to further expand our understanding of the roles different clinical measurements can have in the diagnosis of AD. In this work, we propose a machine learning-based technique to distinguish control subjects with no cognitive impairments, AD subjects, and subjects with mild cognitive impairment (MCI), often seen as precursors of AD. We utilized several machine learning (ML) techniques and found that Gradient Boosting Decision Trees achieved the highest performance above 84% classification accuracy. Also, we determined the importance of the features (clinical biomarkers) contributing to the proposed multi-class classification system. Further investigation on the biomarkers will pave the way to introduce better treatment plan for AD patients.
Refaee, Mahmoud Ahmed; Ali, Amal Awadalla Mohamed; Elfadl, Asma Hamid; Abujazar, Maha F.A.; Islam, Mohammad Tariqul; Kawsar, Ferdaus Ahmed; Househ, Mowafa; Shah, Zubair; and Alam, Tanvir. 2020. Machine Learning Models Reveal The Importance of Clinical Biomarkers for the Diagnosis of Alzheimer's Disease. Studies in Health Technology and Informatics. Vol.272 478-481. https://doi.org/10.3233/SHTI200599 PMID: 32604706 ISSN: 0926-9630 ISBN: 9781643680927